PUBLICATION
🎥 A look back at Adelis appearance on BFM Business!
November 13, 2025
Discover how Adelis Technologies is driving innovation and shaping the future — watch our CEO’s interview on BFM Business.
For years now, our team is passionated in tools and services development for biologists. We are specialised in biomolecules detection (nucleic acids, proteins, mono and polysaccharides, amino acids, immunoglobins and oligonucleotides) in complex matrices. Our one and only goal is to facilitate research, diagnosis, as well as treatment efficiency prediction and follow-up.
Our solutions are created for your needs, offering you simplicity, ergonomics and time saving. Adelis aims to answer today and tomorrow challenges, particularly the growing global demand for high sensitivity analytical methods to measure DNA size and concentration in biological matrices. This trend is particularly true in the field of oncology and the study of cfDNA.
Online concentration
Size separation
Online purification
Online collection
BIABooster hub is based on the use of μLAS technology (micro Laboratory for Analysis and Separation of DNA). It enables simultaneous concentration and separation instead of sequential steps with classical methods.
µLAS Technology is a new paradigm for DNA handling which usually requires a large number of operations involving multiple technologies.
In oncology, the use of cfDNA as a biomarker allows to differentiate cancer patients from healthy people and to follow the efficiency of a drug therapy. With leading academic and health organisations, our clinical research programmes aim to develop cfDNA size and concentration profiling for treatment results prediction and cancer detection tests.
